Plan a safe path
CT, ultrasound, or other imaging helps locate the tumor, map nearby anatomy, and choose a route for the cryoprobes.
Cryoablation · Los Angeles
Focused cold, planned around the tumor and healthy kidney.
EVSLA reviews the diagnosis, actual CT or MRI, tumor size and location, nearby anatomy, kidney function, biopsy needs, surgical options, and the wider care plan to determine whether cryoablation may fit.
Cryoablation is for selected kidney tumors and patients. An evaluation does not guarantee candidacy, complete tumor destruction, kidney preservation, response, or a specific outcome.

Thin cryoprobes are positioned under imaging guidance.
Imaging helps the physician assess target coverage.
Ablation is evaluated within the full urology and cancer plan.
The conversation begins with what the mass is likely to be, whether it needs treatment now, and which option best protects the whole kidney-care plan.
A biopsy may help in some cases. The team also considers whether surveillance, surgery, radiation, or another approach is more appropriate.
Size, location, visibility on imaging, and a safe route for one or more cryoprobes shape eligibility.
The specialist reviews the bowel, ureter, collecting system, vessels, nerves, and healthy kidney tissue around the target.
Renal function, the other kidney, prior surgery, bleeding risk, overall health, and personal priorities all matter.
Imaging guides the physician to the tumor and helps monitor a controlled ice zone. The exact approach is individualized to the anatomy and treatment goal.
CT, ultrasound, or other imaging helps locate the tumor, map nearby anatomy, and choose a route for the cryoprobes.
One or more thin probes are guided through small skin punctures and into the selected tumor under real-time imaging.
Extreme cold freezes the targeted tissue. Imaging helps the specialist monitor the treatment zone and its relationship to nearby structures.
Anesthesia, procedure time, observation, recovery, and follow-up vary with tumor location, complexity, kidney function, health, and the approach used.
The team reviews imaging, diagnosis, kidney function, medications, bleeding risk, prior care, and the role cryoablation would play.
The physician positions the cryoprobes, creates the planned ice zone, and monitors the target and surrounding anatomy.
Your care team gives individualized activity and symptom instructions, then uses CT or MRI and clinical follow-up to assess the treated area.
Your specialist reviews the tumor, probe path, nearby anatomy, kidney function, surgical options, and treatment goal before recommending cryoablation or another next step.

Specialty training in oncology and other image-guided treatments, with a direct approach to complex decisions.
Meet Dr. Dermendjian →
Clear communication and collaborative planning for complex vascular and minimally invasive care.
Meet Dr. Kansagra →
Interventional oncology experience supporting careful planning for selected tumor ablation cases.
Meet Dr. Mathevosian →You do not need to choose a physician before requesting care. EVSLA will route the case based on the clinical question, records, and availability.
Choose the clinic most convenient for your evaluation. Procedure location and availability depend on the treatment and clinical need, and the scheduling team will confirm the appropriate site.
445 W Broadway
Glendale, CA 91204
2750 Sycamore Drive, Suite 200
Simi Valley, CA 93065
1407 Foothill Boulevard
La Cañada Flintridge, CA 91011
Clear answers about candidacy, treatment, surgery, biopsy, risks, recovery, and follow-up.
Kidney cryoablation is an image-guided local treatment. A specialist places one or more thin cryoprobes into a selected kidney tumor and uses extreme cold to create a controlled ice zone intended to destroy the targeted tissue.
Cryoablation may be considered for selected patients with a localized kidney tumor that can be safely reached and covered by a planned ice zone. The decision also depends on diagnosis, tumor size and location, kidney function, nearby anatomy, surgical options, overall health, and treatment goals.
Partial nephrectomy surgically removes the tumor and a margin while preserving the remaining kidney. Percutaneous cryoablation reaches the tumor through small skin punctures and destroys targeted tissue in place. Surgery remains the standard treatment for many localized kidney cancers, while ablation may fit selected patients and tumors.
A renal-mass biopsy may help confirm the diagnosis and guide treatment, but whether and when it is needed depends on the imaging, clinical situation, and care plan. The treating team should explain the role and timing of biopsy for the individual case.
Pain, bruising, fatigue, nausea, fever, or urinary changes can occur. Other risks include bleeding, infection, medication or anesthesia reactions, injury to the kidney or nearby structures, reduced kidney function, incomplete treatment, and tumor recurrence. Some procedures are outpatient while others require overnight observation; discharge timing, activity limits, and recovery vary.
Follow-up CT or MRI and clinical review are used to assess the ablation zone and look for remaining or returning tumor. The timing and type of follow-up depend on the diagnosis, kidney function, treatment details, and the wider cancer-care plan.
Share your current kidney imaging, diagnosis or biopsy information, recent renal-function labs, and urology plan. EVSLA can review the full picture and explain whether cryoablation—or another option—makes sense to discuss.